Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aequus Pharmaceuticals Inc (TSE:AQS)
TSXV:AQS
Aequus Pharmaceuticals (AQS) Financial Statements
13 Followers
Aequus Pharmaceuticals Financial Overview
| Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | C$ 13.36K | C$ 98.41K | C$ 92.25K | C$ 383.07K | C$ 347.92K |
| Gross Profit | C$ 2.90K | C$ 51.93K | C$ 53.26K | C$ 326.58K | C$ 323.30K |
| EBIT | C$ -767.87K | C$ -668.61K | C$ -714.83K | C$ -989.98K | C$ -494.10K |
| EBITDA | C$ -733.12K | C$ -633.86K | C$ -680.09K | C$ -955.16K | - |
| Net Income Common Stockholders | C$ -803.65K | C$ -700.88K | C$ -744.32K | C$ -1.02M | C$ -500.47K |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | C$ 156.87K | C$ 75.24K | C$ 89.03K | C$ 294.67K | C$ 809.16K |
| Total Assets | C$ 1.17M | C$ 885.05K | C$ 962.72K | C$ 1.69M | C$ 2.67M |
| Total Debt | C$ 717.49K | C$ 3.34M | C$ 2.86M | C$ 2.78M | C$ 2.83M |
| Net Debt | C$ 560.62K | C$ 3.26M | C$ 2.77M | C$ 2.49M | C$ 2.02M |
| Total Liabilities | C$ 4.76M | C$ 3.68M | C$ 3.08M | C$ 3.07M | C$ 3.04M |
| Stockholders Equity | C$ -3.59M | C$ -2.79M | C$ -2.12M | C$ -1.38M | C$ -363.79K |
| Cash Flow | - | ||||
| Free Cash Flow | - | C$ -475.15K | C$ -266.99K | C$ -446.47K | C$ -1.51M |
| Operating Cash Flow | - | C$ -475.15K | C$ -266.99K | C$ -446.47K | C$ -1.51M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | C$ 461.36K | C$ 61.36K | C$ -68.03K | C$ -121.16K |
Aequus Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.